FDA warned NuScience Peptides that it sells unapproved injectable peptide drugs, including GLP-1 and tesamorelin products, on its website.
What happened
FDA reviewed the company's website, nusciencepeptides.com, in July 2026 and found nine products marketed with claims to treat or affect conditions such as obesity, type 2 diabetes and sexual function. FDA said the products are drugs and new drugs with no approved application, and that selling bacteriostatic water alongside them and a "peptide calculator" shows the water is meant for making injectable drugs for people.
What FDA found
The website claims these peptides treat or affect the body, which makes them drugs under the law.
Section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)The products are not generally recognized as safe and effective and have no FDA-approved application, so they are unapproved new drugs.
Sections 201(p) and 505(a) of the FD&C Act, 21 U.S.C. 321(p) and 355(a)Shipping these unapproved new drugs across state lines breaks the law.
Sections 301(d) and 505(a) of the FD&C Act, 21 U.S.C. 331(d) and 355(a)Bacteriostatic water sold together with the peptides and a peptide calculator is itself a drug intended for injection.
Section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1)Labels saying "for laboratory, research, and analytical use" and "not intended for human use" do not override the website's drug claims.
21 CFR 201.128
What FDA wants
FDA tells the company to find the root causes, correct the violations and prevent them from recurring, and to send a written response with the steps taken and supporting documents. The response is due within 15 business days of receiving the letter, sent to FDAAdvisory@fda.hhs.gov with reference number 733652 in the subject line.
Who should pay attention
- clinics, med spas and resellers that buy research-labeled peptides
- other online peptide sellers making similar weight-loss and hormone claims
- consumers buying injectable peptides online
This is a summary. Read the original letter on fda.gov.